Press release
Curetis to Present Data from Unyvero LRT U.S. FDA Clinical Trial at ASM Microbe
10 Apr 2017 08:13 CEST
Company Name
CURETIS
ISIN
NL0011509294
Connect_20170410_curetis_pr_en_pneumonia-lrt_data_approved.pdf
Connect_20170410_curetis_pr_de_pneumonia-lrt_data_approved.pdf